The Entheogenic Evolution

I'm joined this week by Prash Puspanathan and Agnieszka Sekula from Enosis Therapeutics, an Australian-based company looking to develop and implement virtual reality in psychedelic therapy as applied in specific stages of the therapeutic process. You can learn more about Enosis at www.enosistherapeutics.com 

My guest for this episode is author, Sean Manseau, and we discuss the very curious and interesting ideas articulated in his book, A.P. Psychedelics: Going Beyond Set and Setting to Achieve Visionary Virtuosity, and if you've ever wondered what creating an emotionally-charged rock and pop music playlist, large doses of mushrooms, magical practices, and experimental ritual theater might have to do with each other, then this is the interview for you! 

Author, death doula, and founder of PlantMedicinePeople.com, Kat Courtney is my guest this week. We have a wide-ranging conversation about serving psychedelic medicines in the modern west, creating new models for non-indigenous people using traditional medicines, working with integrity, self-care, personal growth, and so much more. 

My guest this week is founder of Psoiree.com, an online membership-based community for those seeking fellowship and support for heroic and super-heroic mushroom doses and the Psychedelic Diaries podcast, Ray Christian. We talk about the online community, Ray's entry into the world of psychedelics, podcasting, and more. You can find him and his work online at www.psoiree.com, and you can join up with the promo code "50Martin" to receive a discount on membership. 

My guest this week is Victoria Wueschner, Founder and President at F.I.V.E., Director of Education at Kaivalya Kollectiv, Head Retreat Leader at Tantava Retreats, and also contributor to the anthology, Facilitating 5-MeO-DMT. We had a great conversation about Victoria's entry into the world of 5-MeO, her emphasis on training, support, and integration, and how she's working to educate others about the potentials of 5-MeO-DMT and serve with integrity. 

My guest this week is James Lanthier, CEO of Mindset Pharma of Toronto, Canada, a company that is seeking to develop novel psychedelic analogues to existing psychedelics such as psilocybin, DMT, and 5-MeO-DMT for more targeted delivery, efficacy, and therapeutic potential for use in the developing psychedelic healthcare field. You can find them online at www.mindsetpharma.com